Evidence map›Paper›PMID 33500540›Full record

ArticleJournal of human genetics2021

Clinical characterization and further confirmation of the autosomal recessive SLC12A2 disease.

Monis Bilal Shamsi, Mohamed Saleh, Makki Almuntashri, Essa Alharby, Manar Samman, Roy W A Peake, Fatima M Al-Fadhli, Ali Alasmari, Eissa A Faqeih, Naif A M Almontashiri

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. NKCC1 in human diseases: is theAmerican journal of physiology. Cell physiology · 2023
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Monis Bilal ShamsiCenter for Genetics and Inherited Diseases, Taibah University, Almadinah Almunwarah, Saudi Arabia.
Mohamed SalehSection of Medical Genetics, Children's Specialist Hospital, King Fahad Medical City, Riyadh, Saudi Arabia.
Makki AlmuntashriDepartment of Medical Imaging, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Essa AlharbyCenter for Genetics and Inherited Diseases, Taibah University, Almadinah Almunwarah, Saudi Arabia.
Manar SammanMolecular Pathology, Pathology and Clinical Laboratory Medicine Administration, King Fahad Medical City, Riyadh, Saudi Arabia.
Roy W A PeakeDepartment of Laboratory Medicine, Boston Children's Hospital, Boston, MA, USA.
Fatima M Al-FadhliUnit of Genetic Diseases, Department of Pediatrics, Maternity and Children's Hospital, Almadinah Almunwarah, Saudi Arabia.
Ali AlasmariSection of Medical Genetics, Children's Specialist Hospital, King Fahad Medical City, Riyadh, Saudi Arabia.
Eissa A FaqeihSection of Medical Genetics, Children's Specialist Hospital, King Fahad Medical City, Riyadh, Saudi Arabia.
Naif A M AlmontashiriCenter for Genetics and Inherited Diseases, Taibah University, Almadinah Almunwarah, Saudi Arabia. nmontashri@taibahu.edu.sa.ORCID http://orcid.org/0000-0003-3607-395X
Taibah University · SABoston Children's Hospital · USKing Fahd Medical City · SAKing Saud bin Abdulaziz University for Health Sciences · SAMaternity and Children's Hospital · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heterozygous pathogenic variants in SLC12A2 are reported in patients with nonsyndromic hearing loss. Recently, homozygous loss-of-function variants have been reported in two patients with syndromic intellectual disability, with or without hearing loss. However, the clinical and molecular spectrum of SLC12A2 disease has yet to be characterized and confirmed. Using whole-exome sequencing, we detected a homozygous splicing variant in four patients from two independent families with severe developmental delay, microcephaly, respiratory abnormalities, and subtle dysmorphic features, with or without congenital hearing loss. We also reviewed the reported cases with pathogenic variants associated with autosomal dominant and recessive forms of the SLC12A2 disease. About 50% of the cases have syndromic and nonsyndromic congenital hearing loss. All patients harboring the recessive forms of the disease presented with severe global developmental delay. Interestingly, all reported variants are located in the c-terminal domain, suggesting a critical role of this domain for the proper function of the encoded co-transporter protein. In conclusion, our study provides an additional confirmation of the autosomal recessive SLC12A2 disease.

Indexed as

Genetic Predisposition to DiseaseBrainChildChild, PreschoolDeafnessExomeExome SequencingFemaleGenes, RecessiveHomozygoteHumansInfantIntellectual DisabilityMaleMutationPedigreeSLC12A2 protein, humanSolute Carrier Family 12, Member 2

Identifiers

PMID33500540
OpenAlexW3121433083

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.